4//SEC Filing
Schiller Mark C. 4
Accession 0001415889-25-009477
CIK 0001645666other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 8:42 PM ET
Size
6.1 KB
Accession
0001415889-25-009477
Insider Transaction Report
Form 4
Schiller Mark C.
Chief Legal Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-27+4,800→ 12,000 totalExercise: $6.30Exp: 2034-07-10→ Common Stock (4,800 underlying)
Footnotes (1)
- [F1]On July 11, 2024, the Reporting Person was granted an option to purchase 12,000 shares of common stock that vests on July 11, 2025, pending the achievement of non-financial performance criteria and continuing service through such date. On March 4, 2025, the Company's Compensation Committee (the "Committee") certified that certain of the non-financial performance criteria were achieved for 7,200 shares underlying the option. On March 27, 2025, the Committee certified that certain of the non-financial performance criteria were achieved for the remaining 4,800 shares underlying the option and as such, the entire option will vest on July 11, 2025, provided the Reporting Person continues to provide service through such date.
Documents
Issuer
Kezar Life Sciences, Inc.
CIK 0001645666
Entity typeother
Related Parties
1- filerCIK 0002007659
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 8:42 PM ET
- Size
- 6.1 KB